32 filings
8-K
Translate Bio, Inc.
14 Sep 21
Completion of Acquisition or Disposition of Assets
10:12am
8-K
Translate Bio, Inc.
3 Aug 21
Tender and Support Agreement
8:03am
8-K
Translate Bio, Inc.
16 Jun 21
Departure of Directors or Certain Officers
4:48pm
8-K
Translate Bio, Inc.
20 Apr 21
Departure of Directors or Certain Officers
4:31pm
8-K
Translate Bio, Inc.
23 Mar 21
Departure of Directors or Certain Officers
4:32pm
8-K
ymecvgd b8
25 Feb 21
Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
4:06pm
8-K
41i5vy
28 Dec 20
Departure of Directors or Certain Officers
4:26pm
8-K
rbtd2n3kqs28hzq9c1
22 Dec 20
Departure of Directors or Certain Officers
4:30pm
8-K
7qt4xddvx7k
25 Aug 20
Regulation FD Disclosure
10:15am
8-K
4tihxtx27hm9y90z2p
20 Jul 20
Other Events
4:17pm
8-K
deebx i8d3rozx
26 Jun 20
Translate Bio Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
57nao35q
23 Jun 20
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines across
6:06am
8-K
onf6l
16 Jun 20
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
bhe7m1r ax
7 Apr 20
Other Events
5:27pm
8-K
7zy8s1
27 Mar 20
Sanofi Pasteur and Translate Bio to collaborate to develop a novel mRNA vaccine candidate againstCOVID-19
6:09am
8-K
cq2b j3budjq373
26 Mar 20
Other Events
4:45pm
8-K
sgs ndabr4y7xmw
13 Jan 20
Results of Operations and Financial Condition
6:50am
8-K
2m3r xmwhh0pfwn5ib
12 Dec 19
Translate Bio Announces Executive Leadership Appointments
4:23pm
8-K/A
p732lw
25 Oct 19
Material Impairments
4:32pm
8-K
9kgsycp mf
18 Sep 19
Translate Bio Announces Pricing of Public Offering of Common Stock
4:16pm